RICE HALL JAMES & ASSOCIATES, LLC Karyopharm Therapeutics Inc. Transaction History

RICE HALL JAMES & ASSOCIATES, LLC portfolio value:

$4.96M
portfolio value

RICE HALL JAMES & ASSOCIATES, LLC quarter portfolio value change:

+21.06%
quarter

Karyopharm Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -30.91% -406.75K shares -970K $5.46 909.08K
Q2 2022 share Decrease -2.16% -29.09K shares -3.97M $4.51 1.31M
Q1 2022 share Increase +5.35% 68.29K shares 1.70M $7.37 1.34M
Q4 2021 share Decrease -8.93% -125.22K shares 50K $6.72 1.27M
Q3 2021 share Decrease -0.53% -7.53K shares -6.38M $5.82 1.40M
Q2 2021 share Decrease -9.83% -153.64K shares -1.89M $10.32 1.40M
Q1 2021 share Increase +0.68% 10.54K shares -7.59M $10.52 1.56M
Q4 2020 share Increase +6.69% 97.28K shares 2.78M $15.48 1.55M
Q3 2020 share Increase +91.02% 693.40K shares 6.81M $14.6 1.45M
Q2 2020 share Increase +27.66% 165.07K shares 2.96M $18.94 761.81K
Q1 2020 share Increase 0.00% 596.74K shares 11.46M $19.21 596.74K